Table 2 : Change in mean plasma levels of hs-CRP, MDA and GSH in the normal control (NC), atherogenic control (AC) and aliskiren treated groups (AT), expressed as mean ± SEM.

parameters Groups
NC AC AT
Plasma GSH (mmol/L) 1.114±0.0338 0.58±0.024* 0.618±0.0262
Plasma MDA(µmol/L) 0.129±0.66 0.561±0.136* 0.261±0.15**
Plasma hs-CRP (µg/L) 33.3±0.78 134.1±1.2* 73.1±3.88**

*p < 0.05, AC compare to NC group.
**p <0.05, AT group compared to AC group.

A Al-Aubaidy et al.Journal of Pharmaceutical Technology and Drug Research  2013 2:11DOI : 10.7243/2050-120X-2-11